EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Outcome Analysis of Distal Third Tibial Fractures Treated With Minimally Invasive Plate Osteosynthesis: Protocol for a Prospective Observational Study

Vivek Takale, Bhushan Patil

JMIR Research Protocols · 2026-11-11 · 15 · e100325

DOI: 10.2196/100325 ↗
AbstractBibliografische Angaben

Abstract

Background Distal third tibial fractures are difficult to treat owing to the subcutaneous anteromedial border of the tibia, its tenuous periosteal vascularity, and the proximity of the fracture to the ankle joint. Minimally invasive plate osteosynthesis (MIPO) using a locking compression plate (LCP) preserves fracture biology by avoiding direct exposure of the fracture site. Objective This study aims to describe the functional and radiological outcomes of closed distal third tibial fractures (Arbeitsgemeinschaft für Osteosynthesefragen/Orthopaedic Trauma Association [AO/OTA] types A, B, and C1) treated with MIPO-LCP in an Indian tertiary care setting. The study is descriptive and hypothesis generating and is not designed as a comparative effectiveness trial. Methods This is a single-center, single-arm, prospective observational cohort study to be conducted at a rural tertiary center in India over 24 months (May 2026 to April 2028). Thirty adults aged 18 to 80 years with closed AO/OTA type A, type B, or type C1 distal third tibial fractures are to be enrolled consecutively. The primary outcomes are the American Orthopaedic Foot and Ankle Society (AOFAS) ankle-hindfoot score at 6 months, administered by an independent assessor, and the time to radiological fracture union, assessed using the Radiographic Union Scale for Tibia (RUST). Secondary outcomes include the Olerud-Molander Ankle Score (OMAS), complications, and time to full weight-bearing. Exploratory regression analysis will be performed. Follow-up is scheduled at 6 weeks, 3 months, 6 months, and 12 months. Results Ethics approval was obtained on July 8, 2025. Enrollment has been ongoing since May 1, 2026. As of September 2026, five participants have been enrolled. Results are expected between 2028 and 2029. Conclusions This protocol will generate prospective, hypothesis-generating data on MIPO outcomes in India. Findings will be descriptive only and, given the sample size limitation (n=30), cannot support definitive claims. Results will inform future comparative trials. Trial Registration Clinical Trials Registry–India CTRI/2026/04/108996; https://tinyurl.com/2j9eh8kp International Registered Report Identifier (IRRID) DERR1-10.2196/100325

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →